APREMILAST ACCORD
As listed in the register: APREMILAST ACCORD 10 MG + 20 MG + 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
10 mg + 20 mg + 30 mg · comprimido recubierto con película
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Apremilast
- Made by
- Accord Healthcare S.L.U.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Otezla). It describes the substance, not this exact product.
Apremilast is an oral small molecule inhibitor of phosphodiesterase 4 (PDE4) specific for cyclic adenosine monophosphate (cAMP).
PDE4 inhibition results in increased intracellular cAMP levels.
It is extensively metabolized in humans with up to 23 metabolites identified in plasma, urine and feces.
Co-administration with food does not alter the extent of absorption of OTEZLA.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-09-02
Safety of the active substance
From the US prescribing label for the same active substance (Otezla). It describes the substance, not this exact product.
- OTEZLA/OTEZLA XR is contraindicated in patients with a known hypersensitivity to apremilast or to any of the excipients in the formulation [see Warnings and Precautions (5.1), see Adverse Reactions (6.1) ].
- Known hypersensitivity to apremilast or to any of the excipients in the formulation ( 4 )
The most common adverse reactions presented in Table 3 occurred within the first 2 weeks of treatment and tended to resolve over time with continued dosing.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
Canada9 matching products
- AURO-APREMILAST 10 mg + 20 mg + 30 mg · tablet2 makers
- APO-APREMILAST 10 mg + 20 mg + 30 mg · tablet
- APO-APREMILAST TABLETS 10 mg + 20 mg + 30 mg · tablet
- GLN-APREMILAST 10 mg + 20 mg + 30 mg · tablet
- JAMP APREMILAST 10 mg + 20 mg + 30 mg · tablet
- MAR-APREMILAST 10 mg + 20 mg + 30 mg · tablet
- OTEZLA 10 mg + 20 mg + 30 mg · tablet
- SANDOZ APREMILAST 10 mg + 20 mg + 30 mg · tablet
Netherlands7 matching products
- Apremilast Amarox 10 mg 10 mg + 20 mg + 30 mg · filmomhulde tablet
- Apremilast Devatis 10 mg 10 mg + 20 mg + 30 mg · filmomhulde tablet
- Apremilast HCS 10 mg + 20 mg + 30 mg filmomhulde tabletten 10 mg + 20 mg + 30 mg · filmomhulde tablet
- Apremilast Sandoz 10 mg 10 mg + 20 mg + 30 mg · filmomhulde tablet
- Apremilast STADA 10 mg + 20 mg + 30 mg 10 mg + 20 mg + 30 mg · filmomhulde tablet
- Apremilast Teva 10 mg + 20 mg + 30 mg filmomhulde tabletten 10 mg + 20 mg + 30 mg · filmomhulde tablet
- Tivlemaq 10 mg 10 mg + 20 mg + 30 mg · filmomhulde tablet
SwitzerlandNo exact match for this strength and form
Details
| Made by | Accord Healthcare S.L.U. |
|---|---|
| Active substance | Apremilast |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 10 mg + 20 mg + 30 mg |
| Form | comprimido recubierto con película |
| Classification | L04AA32 · Cancer treatments and immune-system medicines |
| Route | vía oral |
| Marketed | Yes, according to the register |
| Generic | Yes — a generic medicine, according to the register |
| Name in the register | APREMILAST ACCORD 10 MG + 20 MG + 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG |
| Nº Registro | 1241796001 |
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician
Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- comprimido recubierto con película2 products
- 10 mg + 20 mg + 30 mg
- 30 mg
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.